{
    "2020-11-02": [
        [
            {
                "time": "",
                "original_text": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍--醫藥生物上市公司2020年三季報小結",
                "features": {
                    "keywords": [
                        "疫情",
                        "影響",
                        "高成長",
                        "龍頭",
                        "細分冠軍",
                        "醫藥生物",
                        "三季報"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫藥",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商醫藥|三季報】醫療器械、服務：中國製造優勢體現，推薦龍頭",
                "features": {
                    "keywords": [
                        "浙商醫藥",
                        "三季報",
                        "醫療器械",
                        "服務",
                        "中國製造",
                        "優勢",
                        "龍頭"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫療器械",
                        "服務"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}